Most B vitamins do not raise blood sugar, and several appear to support healthy glucose metabolism. The major exception is niacin, also known as vitamin B3, which can meaningfully raise blood sugar when taken in the high pharmacological doses used to manage cholesterol. The remaining B vitamins, from thiamine to biotin to B12, range from neutral to potentially beneficial for blood sugar control, though the evidence varies in strength across the group. The distinction between a standard dietary intake and a therapeutic megadose turns out to matter enormously here.
Niacin Is the B Vitamin That Actually Raises Blood Sugar
When people hear that “B vitamins raise blood sugar,” niacin is almost always the reason. At the doses used clinically to treat high cholesterol and triglycerides, typically 1,000 to 3,000 milligrams per day, niacin can push fasting blood glucose up noticeably. In a study of sedentary postmenopausal women without diabetes, niacin supplementation increased fasting glucose by about 11%, from roughly 95 to 105 mg/dL.1PubMed Central. Niacin increased glucose, insulin, and C-peptide levels in sedentary nondiabetic postmenopausal women Insulin levels in that study jumped even more dramatically, rising over 60%, suggesting the body was working harder to keep blood sugar in check.
This effect isn’t limited to people who are already at risk. A combined analysis of multiple lipid-lowering trials found that even in subjects who started with perfectly normal fasting glucose, niacin treatment was linked to reduced insulin sensitivity, roughly an 18% drop in one sub-study of healthy volunteers.2PubMed Central. Effects of Niacin on Glucose Levels, Coronary Stenosis Progression, and Clinical Events in Subjects With Normal Baseline Glucose Levels In another trial that paired niacin with a statin, the combination still modestly raised fasting glucose by about 3% and fasting insulin by about 19%, while decreasing insulin sensitivity by around 10%.3PubMed Central. Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance
The most alarming data came from the large HPS2-THRIVE trial involving over 25,000 high-risk patients. Extended-release niacin paired with laropiprant (a drug to reduce flushing) increased the rate of new diabetes diagnoses, with a hazard ratio of about 1.32. Among participants who already had diabetes at the start of the trial, serious disturbances in blood sugar control were even more common, with a hazard ratio of 1.56.4Clinical Therapeutics. Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial That trial also showed a significant absolute excess in diabetes-related serious events.5PubMed. Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients Because of results like these, consensus guidelines now recommend monitoring blood sugar after starting niacin therapy or increasing the dose.6Mayo Clinic Proceedings. Effects of Niacin on Glucose Control in Patients With Dyslipidemia
Why Niacin Affects Blood Sugar
The mechanism is not fully nailed down, but the leading explanation centers on how niacin interacts with fatty acids. In the short term, niacin powerfully suppresses the release of free fatty acids from fat tissue. That initial drop in circulating fats can actually improve insulin sensitivity temporarily. The problem is what happens next: the body rebounds. Free fatty acid levels bounce back and often overshoot baseline, and elevated free fatty acids are known to interfere with how cells respond to insulin.
Animal research has confirmed this rebound effect. In a 24-hour infusion study in rats, niacin initially drove free fatty acid levels down by over 60%. But when the infusion continued, fatty acid levels crept back up to normal, and after the infusion stopped, they surged to more than double the starting level. Glucose clamp tests showed that insulin sensitivity improved during the initial phase but became impaired once the rebound kicked in.7PubMed Central. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue This pattern of benefit followed by rebound likely explains why chronic niacin use at therapeutic doses tends to worsen glucose control over time.
It’s worth noting that earlier reports of niacin wrecking blood sugar were often based on small, uncontrolled case reports and studies where high doses were introduced rapidly, sometimes 3 to 6 grams per day.8JAMA. Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease Modern clinical use tends toward lower doses and slower titration, which may blunt the effect somewhat, but does not eliminate it.
What About Nicotinamide, the Other Form of B3?
Niacin comes in two main dietary forms: nicotinic acid, the form responsible for the blood sugar concerns above, and nicotinamide (also called niacinamide). They are chemically related but behave quite differently in the body. Nicotinamide does not cause the flushing that nicotinic acid is notorious for, and it does not have the same lipid-lowering power. Its effects on blood sugar are also milder. A review of high-dose nicotinamide safety noted that studies on its effects on glucose handling and insulin sensitivity have been inconsistent, though minor degrees of insulin resistance have been reported.9Diabetologia. Safety of high-dose nicotinamide: a review
If you are taking a standard B-complex supplement or a multivitamin, the amount of niacin in any form is typically in the range of 20 to 50 milligrams. At that level, there is no meaningful effect on blood sugar. The concern starts at the hundreds-to-thousands-of-milligrams range used for lipid management, a scale that only applies under medical supervision.
Thiamine (B1) May Actually Improve Blood Sugar
While niacin gets all the negative attention, thiamine, or vitamin B1, points in the opposite direction. In a randomized crossover trial of people with elevated blood sugar, high-dose thiamine supplementation (much higher than dietary amounts) significantly reduced the two-hour post-meal glucose level compared to baseline, dropping from roughly 9.9 to 8.8 mmol/L. The placebo group, by contrast, saw their fasting glucose and insulin resistance markers actually worsen over the same period.10PubMed. High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial That is a modest effect, but it is in the helpful direction.
Beyond direct glucose regulation, a lipid-soluble derivative of thiamine called benfotiamine has shown promise in blocking some of the biochemical damage caused by high blood sugar. In lab and animal studies, benfotiamine inhibited multiple pathways of hyperglycemic damage, including inflammation, by activating an enzyme that diverts excess sugar metabolites into less harmful routes.11Nature Medicine. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy This is not the same as lowering blood sugar directly, but it suggests thiamine-related compounds may help protect against the consequences of elevated glucose. Research here is still evolving, and benfotiamine is not part of standard diabetes treatment, but it illustrates how different B vitamins can be from one another when it comes to blood sugar.
Vitamin B6 and Its Relationship With Diabetes
Vitamin B6 is involved in a vast number of metabolic reactions, including many that affect how the body handles glucose. Epidemiological studies have repeatedly found that lower levels of B6 are associated with a higher risk of diabetes, and experimental work suggests B6 plays a protective role against some diabetic complications. A review of the evidence described a clear inverse association between B6 levels and diabetes, meaning people with lower B6 status tend to have worse blood sugar outcomes.12PubMed Central. Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms
What makes the B6 story interesting is the chicken-and-egg problem. Diabetes itself appears to deplete B6, partly through increased oxidative stress and altered metabolism. So low B6 levels in people with diabetes might be both a contributing factor and a consequence of the disease. Either way, there is no evidence that B6 at normal or supplemental doses raises blood sugar. If anything, the data leans toward it being helpful, though the research hasn’t reached the point of clear clinical recommendations for supplementation specifically for blood sugar control.
Riboflavin (B2) and Biotin (B7)
Riboflavin, or vitamin B2, serves as a building block for coenzymes that participate in energy metabolism. Animal research in diabetic mice found that riboflavin supplementation improved glucose uptake in skeletal muscles and fat tissue while reducing oxidative stress, leading the authors to suggest it could help reduce diabetic complications.13PubMed. Ameliorative effect of riboflavin on hyperglycemia, oxidative stress and DNA damage in type-2 diabetic mice: Mechanistic and therapeutic strategies These are animal data, so the translation to humans remains uncertain. But the direction is clearly not toward raising blood sugar.
Biotin has one of the more intriguing profiles among B vitamins in relation to blood sugar. Beyond its well-known role in metabolism, biotin appears to influence gene expression in ways that favor lower blood sugar. It stimulates genes involved in insulin production and insulin receptor activity, while dampening the expression of an enzyme that drives the liver to produce more glucose.14PubMed. Pharmacological effects of biotin Animal studies have also explored how biotin supplementation affects insulin secretion and the proportion of insulin-producing beta cells in the pancreas.15PubMed. Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion Some small clinical trials have combined biotin with chromium and observed improvements in blood sugar markers, but the biotin-specific effect in humans still needs larger trials to pin down confidently. As with B2, there is no signal that biotin raises blood sugar.
B12 and Folate Are a Special Case in Pregnancy
Vitamin B12 and folate (vitamin B9) interact closely, and their balance may matter for blood sugar, particularly during pregnancy. A systematic review and meta-analysis found that higher B12 levels may reduce the risk of gestational diabetes by about 23%.16PubMed Central. Vitamin B12 status and folic acid/vitamin B12 related to the risk of gestational diabetes mellitus in pregnancy: a systematic review and meta-analysis of observational studies What’s more concerning is the scenario where folate is high but B12 is low, a pattern that can occur in women who take folic acid supplements (as recommended in pregnancy) but have an underlying B12 deficiency. This imbalanced state has been flagged as potentially problematic for blood sugar regulation during pregnancy.17PubMed Central. The Relationship Between Folate, Vitamin B12 and Gestational Diabetes Mellitus With Proposed Mechanisms and Foetal Implications
Outside of pregnancy, the relationship between B12 and blood sugar is less dramatic. There is no strong evidence that B12 supplementation at normal doses raises blood sugar. The more relevant clinical concern runs in the other direction: people who already have type 2 diabetes and take metformin face a well-documented risk of B12 depletion over time. A study of patients on prolonged metformin therapy found that B12 deficiency rates increased by about 11%, and that higher cumulative metformin doses correlated strongly with lower B12 levels.18PubMed Central. Vitamin B12 Deficiency and Clinical Neuropathy with Metformin Use in Type 2 Diabetes B12 deficiency can cause nerve damage that mimics or worsens diabetic neuropathy, making screening important for long-term metformin users.
Dietary Amounts Versus Pharmacological Doses
The single most important distinction in this entire topic is dose. A standard multivitamin or B-complex supplement contains B vitamins at levels close to the recommended daily intake, sometimes a few times above it. At these doses, no B vitamin has been convincingly shown to raise blood sugar in a healthy person. The blood sugar concerns with niacin arise specifically at pharmacological doses, 50 to 100 times the amount you’d get from a supplement, prescribed to manage cholesterol.
Large-scale dietary survey data support this distinction. Analysis of NHANES data from 2007 to 2014, covering thousands of U.S. adults, found that dietary intake of B vitamins like folic acid was actually associated with lower fasting blood glucose in people with normal or elevated levels.19PubMed Central. Association of multiple mineral and vitamin B group intake with blood glucose using quantile regression analysis: NHANES 2007-2014 The people eating more B vitamins from food were not seeing higher blood sugar. If anything, the trend went the other way.
So if you are taking a basic B-complex and wondering whether it’s spiking your blood sugar, the answer is almost certainly no. The one scenario where you should pay close attention is if your doctor has prescribed high-dose niacin for lipid management. In that case, blood sugar monitoring is standard practice, and the prescribing physician will already be aware of the risk.
The Metformin and B12 Connection
While not directly about B vitamins raising blood sugar, the metformin-B12 interaction is something that comes up constantly when people with diabetes research B vitamins, and it deserves clear treatment. Metformin is the most widely prescribed first-line medication for type 2 diabetes. It works well for blood sugar, but it interferes with B12 absorption in the gut. The longer someone takes metformin, and the higher the cumulative dose, the more likely B12 levels are to fall.18PubMed Central. Vitamin B12 Deficiency and Clinical Neuropathy with Metformin Use in Type 2 Diabetes
The danger is subtle. Both B12 deficiency and diabetes can cause peripheral neuropathy, the tingling, numbness, and pain in the hands and feet that so many people with diabetes struggle with. When a patient on metformin develops worsening neuropathy, it may be attributed entirely to diabetes when a simple B12 deficiency is partially to blame, and a deficiency that’s far more treatable. This isn’t about B12 affecting blood sugar; it’s about the treatment for blood sugar affecting B12, and the resulting symptoms getting confused. If you take metformin, periodic B12 testing is a reasonable ask of your doctor, particularly if you’ve been on it for several years.
When Gut Bacteria Enter the Picture
An emerging area of research looks at how gut bacteria produce and consume B vitamins, and how this intersects with metabolic health. Certain commensal and probiotic bacteria in the gastrointestinal tract synthesize B vitamins as part of their normal metabolism. These bacterially produced vitamins, along with short-chain fatty acids that gut bacteria also generate, can influence host energy metabolism.20PubMed Central. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria The idea is that a healthy, diverse gut microbiome may contribute to better metabolic function partly through its B vitamin output.
This is still early-stage science, and it would be premature to claim that manipulating your gut bacteria’s B vitamin production could meaningfully change your blood sugar. But it does add nuance to the picture: B vitamin status is not just about what you swallow in a pill. Your gut ecosystem is a contributor too, and disruptions to that ecosystem, through antibiotics, poor diet, or chronic illness, could theoretically affect how much of certain B vitamins your body actually has available.
Common Misconceptions Worth Clearing Up
One persistent misconception is that “B vitamins” are a single thing with a single effect. They are eight distinct compounds with different metabolic roles, different dose-response curves, and very different relationships with blood sugar. Lumping them together makes about as much sense as asking whether “minerals” raise blood pressure. Some do, some don’t, and the dose matters enormously.
Another misconception is that because niacin can raise blood sugar, people with diabetes should avoid all B-vitamin supplementation. This gets the situation backwards for most B vitamins. Thiamine may improve post-meal glucose. B6 deficiency is associated with worse diabetes outcomes. B12 depletion from metformin is a genuine clinical problem that supplementation can fix. Avoiding B vitamins wholesale because of one member’s behavior at pharmacological doses would be counterproductive.
A third myth involves biotin and blood sugar testing. High-dose biotin supplementation, which has been marketed for hair and nail health, can interfere with certain laboratory assays that use biotin-based chemistry. This can produce falsely high or falsely low readings on some blood tests. It does not mean biotin is changing your actual blood sugar. It means the test is giving a wrong number because of a chemical interference in the testing equipment. If you take biotin supplements and get a lab result that seems off, mention the supplement to your doctor so the lab can account for it.